Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$2.32 USD
-0.07 (-2.93%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $2.32 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Adverum Biotechnologies, Inc. has a market cap of $49.93M, which represents its share price of $2.39 multiplied by its outstanding shares number of 20.89M. As a small-cap company, ADVM's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ADVM 2.32 -0.07(-2.93%)
Will ADVM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADVM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADVM
Adverum Biotechnologies (ADVM) Reports Q3 Loss, Tops Revenue Estimates
Adverum Biotechnologies (ADVM) Upgraded to Strong Buy: What Does It Mean for the Stock?
ADVM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic
Bet on 5 Top-Ranked Stocks With Rising P/E
Wall Street Analysts See a 332.28% Upside in Adverum Biotechnologies (ADVM): Can the Stock Really Move This High?
Other News for ADVM
Adverum Biotechnologies (ADVM) Price Target Reduced by Mizuho | ADVM Stock News
Adverum Biotechnologies (ADVM) Price Target Reduced by Mizuho | ADVM Stock News
Adverum Biotechnologies price target lowered to $12 from $16 at Mizuho
Adverum Biotechnologies price target lowered by $4 at Mizuho, here's why
Mizuho Securities Sticks to Their Buy Rating for Adverum Biotechnologies (ADVM)